← Explorer/Network

Mechanisms of Antiinflammatory Action of the Neuroimmunomodulatory Peptide α‐MSH

Lipton JM, Catania A1998Annals of the New York Academy of SciencesReview
10.1111/j.1749-6632.1998.tb09576.xPubMed
CardiovascularEndocrine (ADH/ACTH/MSH)GastrointestinalHypothalamic-PituitaryImmune/InnateMusculoskeletalNeurologicalOcularRespiratory/Sinus
ActinomycetesBacterial EndotoxinsIndoor Mold (Stachybotrys, Aspergillus, etc.)MycotoxinsVolatile Organic Compounds (VOCs)Water-Damaged Buildings (WDB)

Abstract

Abstract:The antiinflammatory effects of α‐melanocyte‐stimulating hormone (α‐MSH) molecules, specifically α‐MSH(1‐13) and its COOH‐terminal tripeptide α‐MSH(11‐13), are well established. The peptides have been effective in tests of all major models of inflammation, and more recent tests have been extended to include experimental inflammatory bowel disease, CNS ischemia/reperfusion injury, and bacterial endotoxin‐induced inflammation within the brain. The broad effectiveness of α‐MSH molecules in all major types of inflammation indicates that the peptides exert actions that are very basic to the inflammatory process. Three general mechanisms of antiinflammatory action of α‐MSH molecules have been identified: inhibition of production of inflammatory mediators by, or inhibition of inflammatory actions of, peripheral host cells; inhibition of peripheral inflammation induced by actions on melanocortin receptors within the brain; inhibition of CNS inflammation by local action of the peptides. It appears that α‐MSH molecules have multiple actions that modulate the primitive inflammatory response.

Key Biomarkers

Alpha Melanocyte Stimulating Hormone (MSH)Immunoglobulin E (IgE)LeptinMatrix Metalloproteinase 9 (MMP9)Vascular Endothelial Growth Factor (VEGF)Visual Contrast Sensitivity (VCS)

Symptom Clusters

Appetite swingsConfusionCoughDifficulty with concentrationExcessive thirstFatigueFrequent urinationHeadacheJoint painLight sensitivityMemory lossMood swingsMuscle achesNight sweatsShortness of breathSinus congestionTingling in extremitiesWord finding difficulty

Cited By (11)

  • Sick building syndrome (SBS) and exposure to water-damaged buildings: Time series study, clinical trial and mechanismsNeurotoxicology and Teratology · 2006
  • α-Melanocyte-stimulating Hormone Inhibits Lipopolysaccharide-induced Tumor Necrosis Factor-α Production in Leukocytes by Modulating Protein Kinase A, p38 Kinase, and Nuclear Factor κB Signaling PathwaysJournal of Biological Chemistry · 2003
  • α-Melanocyte Stimulating Hormone Prevents Lipopolysaccharide-Induced Vasculitis by Down-Regulating Endothelial Cell Adhesion Molecule ExpressionEndocrinology · 2003
  • The Role of α‐MSH as a Modulator of Cutaneous InflammationAnnals of the New York Academy of Sciences · 2000
  • α-Melanocyte-Stimulating Hormone as a Mediator of Tolerance InductionPathobiology · 1999
  • The Melanocortin System: A Promising Target for the Development of New Antidepressant DrugsInternational Journal of Molecular Sciences · 2023

Related Papers

  • Synergistic interaction in simultaneous exposure to Streptomyces californicus and Stachybotrys chartarumEnvironmental Health Perspectives · 2004 · 15 shared tags
  • Correction to “Maitotoxin induces biphasic interleukin-1β secretion and membrane blebbing in murine macrophages”Mol Pharmacol · 2004 · 15 shared tags
  • HUMAN VISUAL FUNCTION IN THE NORTH CAROLINA CLINICAL STUDYON POSSIBLE ESTUARY-ASSOCIATED SYNDROMEJournal of Toxicology and Environmental Health · 2001 · 15 shared tags
  • Cholestyramine protection against ochratoxin A toxicity: role of ochratoxin A sorption by the resin and bile acid enterohepatic circulationJournal of Food Protection · 1999 · 15 shared tags
  • In vitro and in vivo studies to assess the effectiveness of cholestyramine as a binding agent for fumonisinsMycopathologia · 2001 · 15 shared tags
  • Occurrence of Toxigenic Aspergillus versicolor Isolates and Sterigmatocystin in Carpet Dust from Damp Indoor EnvironmentsApplied and Environmental Microbiology · 2002 ·
Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure
Internal Medicine · 2006
  • Peptide Modulation of Inflammatory Processes within the BrainNeuroImmunoModulation · 1998
  • α-Melanocyte-Stimulating Hormone Inhibits NF-κB Activation and IκBα Degradation in Human Glioma Cells and in Experimental Brain InflammationExperimental Neurology · 1999
  • Polymorphism of Melanocortin Receptor Genes—Association with Inflammatory Traits and DiseasesDiseases · 2025
  • α-Melanocyte-stimulating Hormone in Normal Human Physiology and Disease StatesTrends in Endocrinology and Metabolism · 2000
  • References (7)

    • Anti-inflammatory actions of the neuroimmunomodulator α-MSHImmunology Today · 1997
    • Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humorCurrent Eye Research · 1992
    • Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1.The Journal of Immunology · 1986
    • α -MSH Modulates Experimental Inflammatory Bowel DiseasePeptides · 1997
    • Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammationJournal of Clinical Investigation · 1996
    • Alpha- Melanocyte-stimulating hormone induces hapten-specific tolerance in miceThe Journal of Immunology · 1996
    • Antiinflammatory influences of alpha-MSH molecules: central neurogenic and peripheral actionsJournal of Neuroscience · 1994
    15 shared tags